Advanced Skin Cancer Diagnostic Technology in Clinical Settings

Cancer has long been framed as a problem for the second half of life. That’s changing, with early on-set cancers on the rise.

For decades, cancer has been regarded as a disease of aging, shaped by time, accumulation, and years of exposure.
The statistics reinforced that story.

• The median age of cancer patients is 66 or 67, with over 80% of cases occurring in adults over 55.
• 90-95% of cancers have an environmental trigger, such as poor diet, smoking, or exposure to toxins, the effects of which become more significant over time.

But that assumption is changing. Over the past three decades, a quiet but profound shift has been underway.
A growing body of epidemiological evidence shows an increasing number of young adults are being diagnosed with cancers historically seen in older adults. Globally, early-onset cancers (diagnosed before age 50) have increased by nearly 80% between 1990 and 2019, with projections suggesting another 30% rise by 2030.
When it comes to cancer, youth is no longer a defense.

What the Data Shows

In the United States, this trend is subtle but consistent. Analysis of SEER data shows that cancer incidence among adolescents and young adults (ages 15–39) has risen by 0.3% per year over the last decade.4

While cancers still remain far more common in older adults, this increase is statistically significant, and biologically meaningful.

One cancer tells this story very clearly: colon cancer. Recent studies show that colorectal cancer is now the leading cause of cancer-related death in Americans under 50, with incidence increasing by about 1.1% per year since the early 2000s.5
And it isn’t alone. Breast, uterine, pancreatic, kidney, and certain lymphomas follow. These cancers (once considered “later-in-lie” diseases) are appearing earlier, in people in their 30s and 40s, sometimes younger.

What’s Driving This Shift?

• Lifestyle and Metabolic Factors: Rising rates of obesity, sedentary behavior, and diets high in processed foods are strongly associated with cancer risk.
• Screening and Detection: More sensitive imaging and diagnostic tools mean we are finding some cancers earlier that once went unnoticed.
• Environmental Exposures: Chronic low-level exposures to certain chemical pollutants, endocrine disruptors, and other environmental risk factors are under investigation for their potential role.
• Biological and Genetic Susceptibility: In some individuals, inherited risk or early-life biological programming may predispose certain tissues to malignant change earlier than expected.